Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
4226
DELISTED
Aerie Pharmaceuticals
AERI
| $1.46M | ﹤0.01% |
127,814
-78,784
| -38% | -$1.15M |
|
|
LICY.WS
4227
CALL
DELISTED
Li-Cycle Holdings Corp. Redeemable Warrants, each whole warrant exercisable for one Common Share at
LICY.WS
| $1.46M | ﹤0.01% |
+606,349
| New | +$1.11M |
|
|
MAG
4228
DELISTED
MAG Silver
MAG
| $1.45M | ﹤0.01% |
+89,753
| New | +$1.68M |
|
|
TMAC
4229
DELISTED
The Music Acquisition Corporation
TMAC
| $1.45M | ﹤0.01% |
149,474
-3,503
| -2% | -$33.9K |
|
|
TVTY
4230
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $1.45M | ﹤0.01% |
62,952
-44,076
| -41% | -$1.05M |
|
|
IDEX
4231
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $1.45M | ﹤0.01% |
5,889
+4,139
| +237% | +$1.21M |
|
4232
PUT
Johnson Controls International
JCI
$84.6B
| $1.44M | ﹤0.01% |
21,200
+2,000
| +10% | +$144K |
|
|
PRST
4233
DELISTED
Presto Technologies, Inc. Common Stock
PRST
| $1.44M | ﹤0.01% |
144,312
+16,100
| +13% | +$160K |
|
4234
LG Display
LPL
$3.35B
| $1.44M | ﹤0.01% |
181,353
+146,011
| +413% | +$1.34M |
|
4235
MediciNova
MNOV
$70.9M
| $1.44M | ﹤0.01% |
380,019
-299,784
| -44% | -$1.14M |
|
4236
Digital Turbine
APPS
$1.34B
| $1.44M | ﹤0.01% |
20,926
-187,213
| -90% | -$11.6M |
|
4237
PUT
Invesco
IVZ
$14.5B
| $1.44M | ﹤0.01% |
+59,700
| New | +$1.49M |
|
4238
CALL
AstraZeneca
AZN
$252B
| $1.44M | ﹤0.01% |
+11,950
| New | +$1.39M |
|
4239
CALL
New Oriental
EDU
$9.36B
| $1.44M | ﹤0.01% |
+70,000
| New | +$2.22M |
|
4240
PUT
Cemex
CX
$15.7B
| $1.43M | ﹤0.01% |
+200,000
| New | +$1.58M |
|
4241
HCI Group
HCI
$2.32B
| $1.43M | ﹤0.01% |
12,950
-13,026
| -50% | -$1.36M |
|
|
FOLD
4242
PUT
DELISTED
Amicus Therapeutics
FOLD
| $1.43M | ﹤0.01% |
+150,000
| New | +$1.53M |
|
|
SVM
4243
Silvercorp Metals
SVM
$2.82B
| $1.43M | ﹤0.01% |
+375,760
| New | +$1.7M |
|
4244
iShares MSCI USA Value Factor ETF
VLUE
$9.77B
| $1.43M | ﹤0.01% |
+14,213
| New | +$1.48M |
|
4245
PUT
Roper Technologies
ROP
$42.2B
| $1.43M | ﹤0.01% |
+3,200
| New | +$1.53M |
|
|
SFBS
4246
ServisFirst Bancshares
SFBS
$4.72B
| $1.43M | ﹤0.01% |
36,656
-7,086
| -16% | -$254K |
|
|
ALX
4247
Alexander's
ALX
$1.38B
| $1.42M | ﹤0.01% |
5,463
-1,779
| -25% | -$476K |
|
4248
PUT
Insulet
PODD
$10.1B
| $1.42M | ﹤0.01% |
+5,000
| New | +$1.43M |
|
4249
PUT
Diamondback Energy
FANG
$55.4B
| $1.42M | ﹤0.01% |
15,000
-4,800
| -24% | -$386K |
|
4250
Evolus
EOLS
$587M
| $1.42M | ﹤0.01% |
186,044
+137,136
| +280% | +$1.42M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.